SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-001764
Filing Date
2018-02-09
Accepted
2018-02-09 16:07:47
Documents
60
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 Q1'18 10-Q enta-10q_20171231.htm 10-Q 1794739
2 EX-31.1 enta-ex311_8.htm EX-31.1 16200
3 EX-31.2 enta-ex312_6.htm EX-31.2 16186
4 EX-32.1 enta-ex321_7.htm EX-32.1 8931
5 GRAPHIC g2018020917505683519009.jpg GRAPHIC 38272
  Complete submission text file 0001564590-18-001764.txt   6521004

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enta-20171231.xml EX-101.INS 1598515
7 XBRL TAXONOMY EXTENSION SCHEMA enta-20171231.xsd EX-101.SCH 38180
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20171231_cal.xml EX-101.CAL 44841
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20171231_def.xml EX-101.DEF 109286
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20171231_lab.xml EX-101.LAB 293451
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20171231_pre.xml EX-101.PRE 244662
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 18591781
SIC: 2834 Pharmaceutical Preparations